0000899243-20-011919.txt : 20200504 0000899243-20-011919.hdr.sgml : 20200504 20200504182125 ACCESSION NUMBER: 0000899243-20-011919 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200501 FILED AS OF DATE: 20200504 DATE AS OF CHANGE: 20200504 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Fishman Corey N. CENTRAL INDEX KEY: 0001553594 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19879 FILM NUMBER: 20846286 MAIL ADDRESS: STREET 1: DURATA THERAPEUTICS, INC. STREET 2: 89 HEADQUARTERS PLAZA NORTH, 14TH FLOOR CITY: MORRISTOWN STATE: NJ ZIP: 07960 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BIOSPECIFICS TECHNOLOGIES CORP CENTRAL INDEX KEY: 0000875622 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 113054851 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 35 WILBUR ST CITY: LYNBROOK STATE: NY ZIP: 11563 BUSINESS PHONE: 5165937000 MAIL ADDRESS: STREET 1: 35 WILBUR STREET CITY: LYNBROOK STATE: NY ZIP: 11563 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-05-01 0 0000875622 BIOSPECIFICS TECHNOLOGIES CORP BSTC 0001553594 Fishman Corey N. C/O BIOSPECIFICS TECHNOLOGIES CORP. 2 RIGHTER PKWY, DELAWARE CORP. CENTER II WILMINGTON DE 19803 1 0 0 0 Stock Option (Right to Buy) 55.63 2020-05-01 4 A 0 6000 0.00 A 2030-05-01 Common Stock 6000 6000 D The stock options were granted under the BioSpecifics Technologies Corp. 2019 Omnibus Incentive Compensation Plan. The stock options vest in three equal installments over the three-year period following the date of grant. /s/ Corey Fishman by Carl A. Valenstein, attorney- in-fact 2020-05-04